News Horizon Discovery Group plc

Equities

HZD

GB00BK8FL363

Delayed London S.E. Other stock markets			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	+23.00%

2022	Medical Device Innovation Consortium Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics	CI
2020	Horizon Discovery : Acquisition by PerkinElmer Completes	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medical Device Innovation Consortium Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics	22-10-19	CI
Horizon Discovery : Acquisition by PerkinElmer Completes	20-12-23	MT
PerkinElmer (UK) Holdings Ltd. completed the acquisition of Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others.	20-12-22	CI
Horizon Discovery : Takeover by PerkinElmer Gets Court Approval	20-12-22	MT
GFGW LLC : - Form 8.3 - Horizon Discovery Group Plc	20-12-11	PR
Horizon Discovery : Soars 110% on Acquisition by PerkinElmer in $366 Million Deal	20-11-02	MT
PerkinElmer (UK) Holdings Ltd. agreed to acquire Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others for approximately £290 million.	20-11-01	CI
Transcript : Horizon Discovery Group plc, H1 2020 Earnings Call, Aug 17, 2020	20-08-17
Horizon Discovery Group plc Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-17	CI
Horizon Discovery : introduces single cell RNAseq-linked CRISPR screening service	20-08-04	BU
Horizon Discovery Group plc Announces the Addition of Single Cell RNAseq-Linked Pooled CRISPR Screening to Its CRISPR Screening Services Portfolio	20-08-04	CI
Horizon Discovery : Licenses CHOSOURCE Platform to Truebinding for Development and Commercialization of Multiple Biotherapeutics	20-07-29	BU
Horizon Discovery Group plc Licenses Chosource Platform to TrueBinding, Inc for Development and Commercialization of Multiple Biotherapeutics	20-07-29	CI
Transcript : Horizon Discovery Group plc - Analyst/Investor Day	20-07-29
Horizon Discovery Group plc Provides Group Revenue Guidance for the Six Months Ended June 30, 2020	20-07-29	CI
Horizon Discovery : Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	20-07-07	BU
Horizon Discovery Group plc Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	20-07-07	CI
Horizon Discovery : Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	20-05-19	BU
Rentschler Biopharma Licenses Horizon Discovery's Chosource Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	20-05-19	CI
Horizon Discovery Group plc Announces Board Changes	20-05-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Horizon Discovery Group plc

Equities

HZD

GB00BK8FL363

Summary

Filters